Navigation

    Forum

    • Register
    • Login
    • Search
    • Categories
    • Recent
    • Popular
    • Users
    • Groups

    382 - I've had the benefit of reading #84. Is it fair to say that a Rep for Product X who during a call receives an unsolicited request from a physician for a reprint of a journal article, in which the manufacturer had no influence over content, and which contains only "on-label" information, and further provided the Rep does not include any summary of the article, but does discuss the approved benefits of Product X during the call, would not be considered advertising?

    FYI post-approval change/preclearance exemption/what requires review/PAAB scope
    1
    1
    62
    Loading More Posts
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes
    Reply
    • Reply as topic
    Log in to reply
    This topic has been deleted. Only users with topic management privileges can see it.
    • Jennifer Carroll
      Jennifer Carroll last edited by

      This would indeed be considered an advertising activity. The activity clearly relates to the manufacturer’s product and the context in which the activity is unfolding, a promotional (a sales call/visit). This is why you’d want to impose some restrictions including those listed in your question to ensure compliance with legal requirements (e.g. on-label). You’d also want to ensure that the specifics of the activity are aligned with the industry ethics standards. However, there is no advertising content to submit to PAAB in your scenario. PAAB code 1.5 elaborates on the exemption as it relates to materials that have been independently controlled and prepared, with industry involvement limited to purchase and/or sponsorship of the distribution.

      1 Reply Last reply Reply Quote 0
      • First post
        Last post